Today’s Market Takeaways: June 8, 2021

The FDA approved a new Alzheimer’s drug for the first time in nearly 20 years, but it’s not without some controversy. Research Analyst Liz Laprade explains the implications for the health care and biotech sectors in Today’s Market Takeaways. If you have questions for Liz, please send them to info@adviserinvestments.com.